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The cell surface receptors that act as portals of virus entry 
into animal cells have become a focus of renewed interest 
in recent years with the identification of receptor molecules 
(Wimmer, 1994). Genetic manipulation of receptor genes 
has enabled the mapping of virus-binding sites and of the 
normal functions of the receptors. Expression of human 
receptors in transgenic mice (e.g., for polio virus) are pro- 
viding small animal models for studying pathogenesis, 
antiviral therapeutics, and vaccines for human viral patho- 
gens that previously depended on primates for in vivo stud- 
ies. Such models will be of great use when further receptors 
are discovered, e.g., for hepatitis viruses, and accessory 
to CD4 for human immunodeficiency viruses (HIVs). The 
exploitation of viral vectors in gene therapy has also stimu- 
lated investigation into the selective binding and entry of 
viruses into target cells. 
Retroviruses utilize avarietyof apparently unrelated cell 
surface receptors to initiate infection. These receptors 
were first characterized not as molecules, but as genetic 
determinants of pseudotype or vector entry, as reviewed 
elsewhere (Weiss, 1993). The relationship between recep- 
tors was deduced from correlation with the serotype of 
viral envelope antigens, with host range and with blocking 
of receptors by related viruses known as retroviral interfer- 
ence. Thus, avian leukosis-sarcoma viruses (ALVs) are 
classified into cross-neutralization subgroups, A to F, 
which use distinct receptors. Murine type C retroviruses 
are classified on account of receptor utilization into four 
groups: ecotropic (infecting mouse and rat cells), ampho- 
tropic (infecting mouse, human, and other cells), xeno- 
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tropic (infecting only nonmurine cells), and dual-tropic (in- 
fecting murine and mink cells). Using human cells, for 
example, we allocated 2.5 retrovirus strains to eight distinct 
receptor groups through receptor cross-interference stud- 
ies. Figure 1 depicts the six membrane proteins currently 
known to act as receptors for retroviruses. 
Mechanisms of Retrovirus Entry 
The binding of virions to cell surface receptors is but the 
first step in virus entry. The events that lead to fusion of 
the retrovirus envelope with cellular membranes are not 
yet clear. Most retroviruses studied can fuse with cell 
membranes at neutral pH, so the mode of entry does not 
depend on receptor-mediated endocytosis via acidic en- 
dosomes (Weiss, 1993). Ecotropic murine leukemia virus 
(MLV-E), however, is pH-dependent in some cell types, 
possibly relying on cleavage of gp70 by pH-dependent 
cathepsins. 
Each molecule shown in Figure 1 serves as the primary 
binding receptor for its virus, with the sites that affect bind- 
ing and infection (where known) shown by arrows. Al- 
though the receptors represent quite distinct families of 
membrane proteins, the binding sites for several retrovi- 
ruses (HIV, MLV-E, and ALV-A) have a common triplet 
motif requiring an acidic or noncharged amino acid and 
an aromatic one (Zingler et al., 1995). Subsequent to virus 
binding, conformational changes of the receptor, as well 
as of the viral envelope antigens, may occur, as analyzed 
in most detail for CD4 (see Littman, 1995; Weiss, 1993; 
Wimmer, 1994). The envelope glycoproteins of retrovi- 
ruses consist of oligomers of the transmembrane (TM) pro- 
tein each bearing surface (SU) glycoproteins. The SU pro- 
tein mediates binding to specific cellular receptors, 
whereas fusion is dependent on both SU and TM. The 
epitopes for CD4 binding on the HIV SU protein gp120 
are discontinuous (Weiss, 1993), as are those of the MLV 
SU protein gp70 (Battini et al., 1995). 
For HIV, binding to CD4 is not sufficient for entry. Sec- 
Figure 1. Molecular Configuration of the 
Known Retrovirus Receptors 
References: CD4, CAT, Ram-l, and GLVRl 
(reviewed by Wimmer, 1994); CAT (Albritton et 
al., 1993); Ram-l (Miller et al., 1994; van Zeijl et 
al., 1994); GLVRl (Johann et al., 1993; Tailor 
et al., 1993); bovine leukemiavirus (BLV) (Ban 









Region A sequence GALV FeLV-B 
550 - 558 
DTGDVSSKV + + 
. . . . . . . . . + + 
. I . . . . . + + 
Mus musculus -KQEA.T.A 
Mus dunni -UQDA.T.A 
Mus nwlossinus I......M. + nt 
rat E.R..TT.E + 
Figure 2. Variation of the GALV Receptor 
Amino acid sequence of region A (residues 550-558) of GLVRI from 
different species (Johann et al., 1993; Tailor et al., 1993; Wilson et 
al., 1994b). The amino acid numbering of human GLVRl is adopted 
for each receptor protein, Identical amino acids to human GLVRI are 
indicated by elipses. nt, not tested. 
ondary receptors are required to trigger fusion (Weiss, 
1993). The variable loops on gp120, VlN2, and V3 deter- 
mine the secondary tropisms of HIV-1 for CDCpositive T 
helper lymphocytes and macrophages. These epitopes, 
which are also the principle neutralizing antigens, interact 
with secondary glycolipids, which may be receptors 
(Dragic et al., 1995). One glycolipid that can act as a pri- 
mary binding receptor for HIV-1 is galactosyl ceramide, 
although it is not an efficient receptor for HIV entry. Gp120 
interaction with receptors other than CD4 may play a role 
in brain pathogenesis, as gpl20 expression in the brains 
of transgenic mice induces degenerative changes similar 
to those seen in AIDS dementia (Toggas et al., 1994). 
HIV-2 recognizes different secondary receptors from 
HIV-1 and can fuse and enter a wider variety of CD4- 
positive cells (McKnight et al., 1994). HIV-2 also infects 
some CD4-negative cells for which soluble CD4 enhances 
rather than inhibits infection (Weiss, 1993; Talbot et al., 
1995). 
Transporter Receptors: Specificity and Function 
The receptors with multiple membrane-spanning domains 
shown in Figure 1 function as transporter molecule8 (see 
Wimmer, 1994). The MLV-E receptor is a cationic amino 
acid transporter (CAT) for arginine, lysine, and ornithine 
(Kim et al., 1991; Wang et al., 1991). GLVRl, the receptor 
for gibbon ape leukemia virus (GALV) and feline leukemia 
virus B (FeLV-B), and Ram-l, the receptor for MLV-A, are 
both Pi (inorganic phosphate) transporters. Whereas CAT 
functions independently of Na’, GLVRl and Ram-l are 
dependent on Na+ and transport is inhibited if the Na+ is 
replaced by K+ or Lif (Kavanaugh et al., 1994; Clah et al., 
1994). 
The amino acid sequences of these transporter mole- 
cules are highly conserved among eukaryotes, reflecting 
the unchanging nature of their crucial housekeeping func- 
tions in cell membranes. However, the epitopes that are 
critical for virus binding and infection vary greatly among 
mammalian species without affecting transport function. 
One or few amino acids determine permissivity for infec- 
tion. The inability of human CAT to function as a receptor 
for MLV-E is attributable to variation of two amino acids 
of the third extracellular loop PGV(242-244) as opposed 
to YGE(235-237) in murine CAT (Albritton et al., 1993). 
Similarly, sequence variation in the fourth extracellular 
loop (region A; residues 550-558) of GLVRl accounts for 
the differential in permissivity of human, rat, and murine 
GLVRl to GALVand FeLV-B (Figure2)(Tailoret al., 1993). 
Variation within this region may also account for the inabil- 
ity of Ram-l to function for GALV. The Ram-l homolog 
in hamster E36 cells (EAR) can function as a receptor for 
GALV as well as for MLV-A (Wilson et al., 1994a). 
The 10Al strain of MLV utilizes both GLVRl and Ram-l 
(Wilson et al., 1994a), showing that related type C mamma- 
lian viruses can utilize closely related molecules as recep- 
tors. The receptors for xenotropic and dualtropic MLV 
have yet to be, identified, but the high homology of their 
envelopes with MLV-A and FeLV-B envelopes suggests 
that these viruses may utilize related transporter mole- 
cules as receptors. 
We may speculate that the variability of the virus-binding 
epitopes on receptors from different host species results 
in part from natural selection for virus resistance. For in- 
stance, the amino acid sequence of the GLVRl virus- 
binding epitope is shown in Figure 2. The sequence in 
humans and carnivores is identical, yet there is extraordi- 
nary variation among rodent species, even within the ge- 
nus Mus. GALV is an exogenous, horizontally transmitted 
leukemogenic virus of gibbon apes in South East Asia. 
However, GALV may represent a recent zoonotic infection 
of gibbons from an endogenous retroviral genome of mice 
(M. caroli) that are also indigenous in Southeast Asia 
(Lieber et al., 1975). Indeed, there is no evidence that wild 
arboreal gibbons are naturally infected with GALV, though 
the virus spread in captive colonies. The GLVRl receptor 
sequences of most murine species are not permissive for 
GALV infection. It is possible that they mutated to evolve 
resistance to prevent viremia from activated endogenous 
virus. In other words, receptor mutation subsequent to the 
acquisition and transgenesis of an endogenous virus may 
render it xenotropic or at least nonecotropic. 
Does Virus Infection Affect Normal Receptor 
Function? 
Many retroviruses are able to establish persistent infec- 
tions without obvious cytopathic effects. Yet sufficient en- 
velope glycoproteins are synthesized in persistent, pro- 
ductive infection to cause resistance (interference) to 
superinfection through blocking or down-modulation of re- 
ceptors. It follows that receptor interference is not always 
lethal to cellular functions. The binding of excess gp120 
to CD4 can inhibit CD4-MHC class II interactions, and 
down-modulation of CD4 by HIV gpl20, Nef, and Vpu pre- 
sumably renders a T helper lymphocyte anergic. The pos- 
sible effect of gp120 binding to Gal-Cer glycolipid in the 
brain has already been mentioned. 
The binding of type C viral gp70 to receptors does not 
entirely inhibit their natural permease functions. Amino 
acid transport through the CAT receptor is diminished by 
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MLV-E (Wang et al., 1992), and Pi transport via GLVRI 
and Ram-l is inhibited by GALV and MLV-A, respectively 
(Kavanaugh et al., 1994; Olah et al., 1994). It remains to 
be determined whether cell survival following productive 
retrovirus infection is possible because gp70 incompletely 
blocks physiological transport or because there is redun- 
dancy among transporter systems. As Pi starvation up- 
regulates GLVRl and Ram-l (Kavanaugh et al., 1994), 
any inhibition of Pi transport in cells productively infected 
with either GALV or MLV-A might be compensated for by 
the up-regulation of the “free” transporter. While the dou- 
ble infection by GALV and MLV-A of dually permissive cells 
might block Pi transport sufficiently to cause a deleterious 
effect, it is also feasible that other Pi transporters, which 
do not function as receptors for either GALV or MLV-A, 
may exist to compensate for the inhibition of Pi transport 
by GLVRl and Ram-i. 
It should be borne in mind that viral interference has 
been studied in vitro, and the levels of virus glycoprotein 
production in vivo may be insufficient to block the normal 
functions of retroviral receptors. However, endogenous 
viral glycoprotein expression can saturate receptors suffi- 
ciently to block infection in vivo, as exemplified by the 
Mendelian dominant resistance of chickens expressing 
endogenous envelope to ALV-E infection and an analog 
in mice, the Fv-4 locus (reviewed by Weiss, 1993). 
The interaction of retroviral glycoproteins with cell sur- 
face receptors can also result in receptor activation. This is 
exemplified by the association of Friend erythroleukemia 
virus gp55 with the erythroprotein receptor (EpoR). Gp55 
is an aberrant, recombinant envelope glycoprotein en- 
coded by the replication-defective, spleen focus-forming 
component of Friend virus, and it does not mediate virion 
entry. But it activates signal transduction by EpoR in the 
absence of Epo, thus promoting erythroid proliferation (Li 
et al., 1995). 
Targeting Novel Receptors with Retroviral Vectors 
The Ram-l and GLVRl receptors are broadly expressed 
in human tissues (Miller et al., 1994), as are receptors 
for the RD114 feline envelope that resists inactivation by 
human complement (Takeuchi et al., 1994). There is grow- 
ing interest, however, in modifying retroviral envelopes to 
target cell types more specifically. Kasahara et al. (1994) 
reported targeting of retroviral vectors to EpoR through 
the incorporation of Epo into gp70. Somia et al. (1995) 
have produced an efficient vector targeted to the low den- 
sity lipoprotein receptor by insertion into ecotropic env of 
a single-chain immunoglobulin fragment specific to low 
density lipoprotein receptor. Oligomeric envelope spikes 
containing wild-type gp70 and modified gp70 may in- 
crease efficiency of infection (Chu and Dornburg, 1995). 
However, while insertion of an epidermal growth factor 
motif specifically targeted retroviral particles to cells ex- 
pressing epidemal growth factor receptors, infection was 
inefficient (Cosset et al., 1995). These results indicate that 
modified gp70-containing ligands for nonviral receptors 
can, but do not always, serve as functional viral glycopro- 
is likely to provide improved specificity of vectors for gene 
therapy. 
References 
Albritton, L. M., Kim, J. W., Tseng, L., and Cunningham, J. M. (1993). 
J. Virol. 67, 2091-2096. 
Ban, J., Portetelle, D., Altaner, C., Horion, B., Milan, D., Krchnak, V., 
Burny, A., and Kettman, Ft. (1993). J. Virol. 67, 1050-1057. 
Bates, P., Young, J. A. T., and Varmus, H. E. (1993). Cell 74, 1043- 
1051. 
Battini, J. L., Danos, O., and Heard, J. M. (1995). J. Virol. 69, 713- 
719. 
Chu, T. T., and Dornburg, R. (1995). J. Virol. 69, 2569-2663. 
Cosset, F. L., Takeuchi, Y., Morling, F., Weiss, R. A., Collins, M. K. L., 
and Russell, S. (1995). J. Virol., in press. 
Dragic, T., Picard, L., and Alizon, M. (1995). J. Virol. 69, 1013-1016. 
Johann, S. V., Zeijl, M. V., Cekleniak, J., and O’Hara, 8. (1993). J. 
Virol. 67, 6733-6736. 
Kasahara, N., Dozy, A. M., and Kan, Y. W. (1994). Science 266,1373- 
1376. 
Kavanaugh, M. P., Miller, D. G., Zhang, W., Law, W., Kozak, S. L., 
Kabat, D., and Miller, A. D. (1994). Proc. Natl. Acad. Sci. USA 97, 
7071-7075. 
Kim, J. W., Gloss, E. I., Albritton, L. M., and Cunningham, J. M. (1991). 
Nature 35.2, 725-726. 
Li, J. P., Hu, H., Niu, Cl., and Fang, C. (1995). J. Virol. 69, 1714-1719. 
Lieber, M. M., Sherr, C. J., Todaro, G. T., Beneviste, R. E., Callahan, 
R., and Coon, H. G. (1975). Proc. Natl. Acad. Sci. USA 72, 2315- 
2319. 
Littman, D., ed. (1995). Curr. Topics Microbial. Immunol. 205. 
McKnight, A., Clapham, P. Ft., and Weiss, R. A. (1994). Virology 207, 
a-18. 
Miller, D. G., Edwards, R. H., and Miller, A. D. (1994). Proc. Natl. Acad. 
Sci. USA 91, 78-82. 
Olah, Z., Lehel, C., Anderson, W. B., Eiden, M. V., and Wilson, C. A. 
(1994). J. Biol. Chem. 269, 25426-25431, 
Somia, N. V., Zoppe, M., and Verma, I. M. (1995). Proc. Natl. Acad. 
Sci. USA, in press. 
Tailor, C. S., Takeuchi, Y., O’Hara, B., Johann, S. V., Weiss, R. A., 
and Collins, M. K. L. (1993). J. Virol. 67, 6737-6741. 
Takeuchi, Y., Cosset, F. L., Lachmann, P. J., Okada, H., Weiss, R. A., 
and Collins, M. K. L. (1994). J. Virol. 68, 6001-6007. 
Talbot, S. J., Weiss, R. A., and Schulz, T. F. (1995). J. Virol. 69,3399- 
3406. 
Toggas, S. M., Masliah, E., Rockenstein, E. M., Rail, G. F., Abraham, 
C. R., and Mucke, L. (1994). Nature 367, 166. 
Wang, H., Kavanaugh, M. P., North, R. A., and Kabat, D. (1991). Nature 
352, 729-731. 
Wang, H., Dechant, E., Kavanaugh, M., North, Ft., and Kabat, D. 
(1992). J. Biol. Chem. 267, 23617-23624. 
Weiss, R. A. (1993). Cellular receptors and viral glycoproteins involved 
in retroviral entry. In The Retroviridae, J. Levy, ed. (New York: Plenum 
Press), pp. i-108. 
Wilson, C. A., Farrell, K. B., and Eiden, M. V. (1994a). J. Virol. 68, 
7697-7703. 
Wilson, C. A., Farrell, K. B., and Eiden, M. V. (1994b). J. Gen. Virol. 
75, igot-1908. 
Wimmer, E. (1994). Cellular Receptors for Animal Viruses (Cold Spring 
Harbor, New York: Cold Spring Harbor Laboratory Press). 
Zeijl, M.V., Johann, S.V.,Cross, E., Cunningham, J., Eddy, R., Shows, 
T. B., and O’Hara, B. (1994). Proc. Nag. Acad. Sci. USA 91, 1166- 
1172. 
teins for vector entry. Nevertheless, engineering retroviral Zingter, k., Bblanger, C., Peters, R., Agard, D., and Young, J. A. T. 
envelopes for specific cell attachment and internalization (1995). J. Virol. 69, 4261-4266. 
